Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. (ORMP)

Market is closed
News
  • Displaying 7
Oramed Pharmaceuticals Inc. (ORMP) Fell Out Of Favor With Hedge Funds

Oramed Pharmaceuticals Inc. (ORMP) Fell Out Of Favor With Hedge Funds

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st...

Keep Reading →

June 18th, 2021 - Hedge Funds News

Is Oramed Pharmaceuticals (ORMP) A Good Stock To Buy Now?

Is Oramed Pharmaceuticals (ORMP) A Good Stock To Buy Now?

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.

Keep Reading →

December 3rd, 2020 - Hedge Funds News

Oramed Pharmaceuticals Inc. (ORMP): Are Hedge Funds Right About This Stock?

Oramed Pharmaceuticals Inc. (ORMP): Are Hedge Funds Right About This Stock?

In this article we will take a look at whether hedge funds think Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) is a good investment right now.

Keep Reading →

June 4th, 2020 - Hedge Funds News

Hedge Funds Have Never Been This Bullish On Oramed Pharmaceuticals Inc. (ORMP)

Hedge Funds Have Never Been This Bullish On Oramed Pharmaceuticals Inc. (ORMP)

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 of 2018 due to various reasons.

Keep Reading →

December 22nd, 2019 - Hedge Funds News

The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP)

The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP)

The problem with being at the top of one of the largest healthcare market niches in the world is extremely heightened expectations.

Keep Reading →

August 9th, 2016 - News Stock Analysis

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362 million, for a growth rate of 28%.

Keep Reading →

June 22nd, 2016 - News Stock Analysis

Why Nobilis Health, Sunrun, Luxoft Holding and Two Other Stocks Are Surging Today?

Why Nobilis Health, Sunrun, Luxoft Holding and Two Other Stocks Are Surging Today?

Markets are headed to conclude the week on a disappointing note after bad retail sector data for April dented the investor sentiment on Friday morning.

Keep Reading →

May 13th, 2016 - Market Movers News

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)